You have 9 free searches left this month | for more free features.

durvalumab

Showing 1 - 25 of 284

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Tumours Trial in Beijing (Ceralasertib, Durvalumab)

Not yet recruiting
  • Advanced Solid Tumours
  • Beijing, China
    Research Site
Aug 23, 2022

Lung Cancer, NSCLC, PD-L1 Gene Mutation Trial in Detroit (Durvalumab, Carboplatin, Pemetrexed)

Withdrawn
  • Lung Cancer
  • +3 more
  • Durvalumab
  • +2 more
  • Detroit, Michigan
    Henry Ford Health System
Feb 15, 2022

Head Neck Cancer Trial in Netherlands (PD-L1 imaging, Durvalumab)

Completed
  • Head and Neck Cancer
  • PD-L1 imaging
  • Durvalumab
  • Amsterdam, Netherlands
  • +3 more
Jan 6, 2022

Extensive-Stage Small-Cell Lung Cancer Trial in Shanghai (durvalumab + anlotinib, Durvalumab)

Recruiting
  • Extensive-Stage Small-Cell Lung Cancer
  • durvalumab + anlotinib
  • Durvalumab
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Nov 1, 2021

Patients With Advanced Treatment Naive LCNEC Trial in Tel Aviv (Durvalumab)

Recruiting
  • Patients With Advanced Treatment Naive LCNEC
  • Durvalumab
  • Tel Aviv, Israel
    Assuta MC
Feb 20, 2022

Resectable Biliary Tract Cancer Trial in Tianjin (Cisplatin, Gemcitabine, Nab-paclitaxel)

Recruiting
  • Resectable Biliary Tract Cancer
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Nov 30, 2022

Durvalumab, Intrahepatic Cholangiocarcinoma, Gemcis Trial in Tianjin (Durvalumab, Surgery, Gemcitabine)

Recruiting
  • Durvalumab
  • +2 more
  • Durvalumab
  • +3 more
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Jan 3, 2023

Non Small Cell Lung Cancer Trial in Lexington (Durvalumab, Copanlisib)

Recruiting
  • Non Small Cell Lung Cancer
  • Lexington, Kentucky
    Markey Cancer Center
Feb 21, 2022

Lung Cancer Trial (Savolitinib, Durvalumab)

Not yet recruiting
  • Lung Cancer
  • (no location specified)
May 13, 2022

Unresectable Hepatocellular Carcinoma Trial (Durvalumab, Tremelimumab)

Available
  • Unresectable Hepatocellular Carcinoma
  • (no location specified)
Aug 12, 2022

Lung Cancer, Extensive-stage Small-cell Lung Cancer, Radiotherapy Trial (Durvalumab + carboplatin/cisplatin + etoposide,

Not yet recruiting
  • Lung Cancer
  • +2 more
  • Durvalumab + carboplatin/cisplatin + etoposide
  • +2 more
  • (no location specified)
Aug 3, 2022

Hepatocellular Carcinoma Trial (Durvalumab, Tremelimumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Sep 27, 2022

Adenocarcinoma of the Pancreas Trial in Miami (Durvalumab, Radiation Therapy)

Active, not recruiting
  • Adenocarcinoma of the Pancreas
  • Durvalumab
  • Radiation Therapy
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Jul 7, 2022

Resectable Hepatocellular Carcinoma, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Boston (Durvalumab, Tremelimumab,

Not yet recruiting
  • Resectable Hepatocellular Carcinoma
  • +2 more
  • Durvalumab
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 18, 2023

Small-cell Lung Cancer, Extensive-stage Small-cell Lung Cancer, Lung Cancer Trial (Ablative Radiation, Durvalumab, Etoposide)

Not yet recruiting
  • Small-cell Lung Cancer
  • +2 more
  • Ablative Radiation
  • +3 more
  • (no location specified)
Mar 11, 2022

Nonsmall Cell Lung Cancer Stage III, Unresectable Non-Small Cell Lung Carcinoma Trial in Winston-Salem (drug, other, diagnostic

Not yet recruiting
  • Nonsmall Cell Lung Cancer Stage III
  • Unresectable Non-Small Cell Lung Carcinoma
  • Durvalumab
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Jan 12, 2023

Early Small (cT1N0) Triple Negative Breast Cancer Trial in Villejuif (Durvalumab)

Recruiting
  • Early Small (cT1N0) Triple Negative Breast Cancer
  • Durvalumab
  • Villejuif, France
    Gustave Roussy
Jan 17, 2022

Stomach Cancer, Adenocarcinoma Trial in Seoul (Durvalumab, Savolitinib)

Not yet recruiting
  • Stomach Cancer, Adenocarcinoma
  • Seoul, Korea, Republic of
    Samsung Medical Center
Nov 17, 2022

Malignant Tumors of Digestive Organs, Colorectal Cancer, Colon Cancer Trial in Houston (Durvalumab, Trametinib)

Completed
  • Malignant Neoplasms of Digestive Organs
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 23, 2022

HNSCC Trial in Avignon, Rennes (Durvalumab)

Recruiting
  • HNSCC
  • Durvalumab
  • Avignon, France
  • +1 more
Mar 10, 2022

Gastric Cancer, Microsatellite Instability Trial in Milan (Durvalumab, Tremelimumab)

Recruiting
  • Gastric Cancer
  • Microsatellite Instability
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Aug 3, 2022

Small Cell Lung Cancer, Lung Cancer Trial in Switzerland (Durvalumab, carboplatin, etoposide)

Recruiting
  • Small Cell Lung Cancer
  • Lung Cancer
  • Durvalumab
  • +3 more
  • Aarau, Switzerland
  • +13 more
Aug 12, 2022

Stage III Non-small-cell Lung Cancer Trial in Providence (Durvalumab, SBRT)

Recruiting
  • Stage III Non-small-cell Lung Cancer
  • Durvalumab
  • SBRT
  • Providence, Rhode Island
  • +1 more
Feb 23, 2022

Biliary Tract Cancer, DNA Damage Repair Deficiency Trial in Seoul (Durvalumab, Olaparib)

Recruiting
  • Biliary Tract Cancer
  • DNA Damage Repair Deficiency
  • Seoul, Korea, Republic of
    Asan Medical Center
Apr 8, 2022

Non Small Cell Lung Cancer Trial in Dallas (Stereotactic radiation therapy, Durvalumab)

Recruiting
  • Non Small Cell Lung Cancer
  • Stereotactic radiation therapy
  • Durvalumab
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Feb 23, 2022